CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on identifying early biomarkers for chronic inflammatory diseases like Crohn's disease, enabling diagnosis before symptoms appear. By validating these biomarkers, the aim is to initiate timely treatments that prevent complications and improve patient outcomes.
Chronic inflammatory diseases such rheumatoid arthritis (RA), multiple sclerosis (MS), type 1 diabetes (t1D) and Crohn’s disease (CD) are increasingly common and cause important loss of quality of life and work productivity.
Most of these conditions are diagnosed at a late stage of the disease; many patients have complications at diagnosis.
For many of these conditions there are now methods or markers in the blood that allow diagnosis in the preclinical phase, meaning that individuals can be ide…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Amsterdam
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Portugal, LISBOA
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Portugal, Lisboa
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Sweden, Orebro
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
